The 31-GEP provides personalized prognostic information beyond AJCC staging in patients with cutaneous melanoma
EJC Skin Cancer · 2026 · 4 · 100925
DOI: 10.1016/j.ejcskn.2026.100925 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2026. Verfasst von A. Jarell und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jarell, A., Gadzia, J., Ackerman, L., Beard, T., Martin, B., Gimbel, M., & Guenther, J. (2026). The 31-GEP provides personalized prognostic information beyond AJCC staging in patients with cutaneous melanoma. EJC Skin Cancer, 4, 100925. https://doi.org/10.1016/j.ejcskn.2026.100925
Vancouver
Jarell A, Gadzia J, Ackerman L, Beard T, Martin B, Gimbel M, et al. The 31-GEP provides personalized prognostic information beyond AJCC staging in patients with cutaneous melanoma. EJC Skin Cancer. 2026;4:100925. doi:10.1016/j.ejcskn.2026.100925
BibTeX
@article{Jarell2026,
author = {Jarell, A. and Gadzia, J. and Ackerman, L. and Beard, T. and Martin, B. and Gimbel, M. and Guenther, J.M.},
title = {The 31-GEP provides personalized prognostic information beyond AJCC staging in patients with cutaneous melanoma},
journal = {EJC Skin Cancer},
year = {2026},
volume = {4},
pages = {100925},
doi = {10.1016/j.ejcskn.2026.100925}
}
EUVIMED